Biotin Reagents in Antibody Pretargeting. 6. Synthesis and in Vivo Evaluation of Astatinated and Radioiodinated Aryl- andnido-Carboranyl-biotin Derivatives
- 30 April 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 15 (3), 601-616
- https://doi.org/10.1021/bc034229q
Abstract
An investigation has been conducted to prepare and evaluate several radiohalogenated biotin derivatives as part of our studies to develop reagents for carrying 211At in cancer pretargeting protocols. The primary goal of the investigation was to determine the in vivo stability and distribution properties of astatinated biotin derivatives. In addition to astatination, the biotin derivatives were radioiodinated for in vitro and in vivo comparison. Biodistributions were conducted in athymic mice, with sacrifice times of 1, 4, and 24 h to correspond to 9%, 32%, and 90% of 211At decay (t1/2 = 7.21 h). In the investigation, two biotin derivatives, 1a and 2a, were synthesized which had structures that contain a biotin moiety, a biotinidase-blocking moiety, an ether linker moiety, and an aryl stannane moiety for radiohalogenation. Biotin derivatives 1a and 2a were radiolabeled with 125/131I to give [125/131I]1b or [125I]2b and with 211At to give [211At]1c or [211At]2c. In vivo studies demonstrated that co-injected [125I]2b and [131I]1b had very similar tissue distributions in athymic mice. Co-injection of [211At]2c and [125I]2b provided data that indicated that rapid deastatination occurred in vivo. A second set of biotin derivatives, 3a, 4a, and 5a, were synthesized which had structures that contain a biotin moiety, a biotinidase-blocking moiety, and an anionic nido-carborane moiety for radiohalogenation. The biotin derivatives 4a and 5a contained an aryl moiety not present in 3a, and 5a had a trialkylamine functionality not present in 3a or 4a. Biotin derivative 3a was radioiodinated, but was not further investigated. Biotin derivatives 4a and 5a were radiolabeled with 211At and 125I to produce [125I]4b/[211At]4c and [125I]5b/[211At]5c. Comparison of [125I]4b and (separately) [125I]5b with [131I]1b showed that the nido-carborane containing biotin derivatives were retained in blood and tissue more than the aryl iodide derivative. In vivo evaluations of [211At]4c/[125I]4b and (separately) [211At]5c/[125I]5b indicated that some deastatination occurred in these compounds, but it was much less than observed for the aryl derivative [211At]2c. While the nido-carborane containing biotin derivatives provide a significant improvement in astatine stability over biotin derivatives previously studied, additional derivatives need to be prepared and studied to further improve the in vivo stability and blood/tissue clearance of these compounds.Keywords
This publication has 10 references indexed in Scilit:
- Reagents for Astatination of Biomolecules: Comparison of the in Vivo Distribution and Stability of Some Radioiodinated/Astatinated Benzamidyl andnido-Carboranyl CompoundsBioconjugate Chemistry, 2003
- Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of CancerChemical Reviews, 1999
- Astatine-211-Labeled Biotin Conjugates Resistant to Biotinidase for Use in Pretargeted RadioimmunotherapyNuclear Medicine and Biology, 1998
- PretargetingCancer, 1997
- Approaches to improved antibody- and peptide-mediated targeting for imaging and therapy of cancerJournal of Controlled Release, 1994
- Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab′)2Nuclear Medicine and Biology, 1993
- Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-[211At]astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugateBioconjugate Chemistry, 1991
- Monoclonal antibody pretargetting techniques for tumour localizationNuclear Medicine Communications, 1991
- Reactions of Organometallic Compounds with Astatine-211. Application to Protein LabelingRadiochimica Acta, 1989
- Synthesis and antibody-labeling studies with the p-isothiocyanatobenzene derivatives of 1,2-dicarba-closo-dodecarborane(12) and the dodecahydro-7,8-dicarbanido-undecaborate(-1) ion for neutron-capture therapy of human cancer. Crystal and molecular structure of Cs+[nido-7-(p-C6H4NCS)-9-I-7,8-C2B9H11]-Inorganic Chemistry, 1985